Delivery Order SPE2DB24D1021-SPE2DB25FFBCS
- Not listed
- The Defense Logistics Agency awarded a $2,786.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Diprivan 500 mg/50 mL vials. This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery location is specified as Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 19, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver Diprivan 1,000 mg/100 mL vials with a ceiling value of $1,103.87 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,359.52 for Diprivan (propofol) 1,000 mg/100 mL vials on September 17, 2025, with completion targeted for September 18, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,382.85 firm fixed-price delivery order is for the supply of 4,560,070,869 units of the medication Diprivan 1,000 mg/100 ml vial with a completion date of February 28, 2023. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm-fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,146.14 firm fixed-price delivery order is for the supply of 4559450870 - DIPRIVAN 1,000 MG/100 ML VIAL 100ML, an injectable medication. The contract has an ultimate completion date of December 27, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide a variety of pharmaceutical products and medical supplies, including the anesthetic drug Diprivan. The contract, valued at $3,222.54, has a firm fixed price structure and a completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,194.18 firm fixed-price delivery order is for the supply of 1,000 mg/100 ml vials of the drug Diprivan. The contract has an ultimate completion date of October 23, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order under a larger Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4,565,617,895 units of the drug DIPRIVAN 200 MG/20 ML VIAL 20ML. The order has a firm fixed price of $1,926.60 and a completion date of August 29, 2024. AmerisourceBergen holds a significant IDC with DLA Troop Support Medical valued at up to $999,999,999 for delivering a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of DIPRIVAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a potential value of $1,043.13 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBCSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,713.93 to AmerisourceBergen Drug Corp for the supply of Diprivan 500 mg/50 mL vials. This non-set-aside, competitively awarded contract was executed on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a pharmaceutical procurement transaction supporting federal medical supply requirements. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems, with extensive experience fulfilling federal procurement requirements for a comprehensive range of pharmaceutical products and medical supplies. The parent IDC enables the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including services to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/23/25 |